Emcure Pharmaceuticals inches up on getting nod to incorporate wholly-owned subsidiary

16 Sep 2024 Evaluate

Emcure Pharmaceuticals is currently trading at Rs. 1421.30, up by 0.65 points or 0.05% from its previous closing of Rs. 1420.65 on the BSE.

The scrip opened at Rs. 1439.00 and has touched a high and low of Rs. 1453.40 and Rs. 1419.90 respectively. So far 1828 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1461.95 on 11-Sep-2024 and a 52 week low of Rs. 1226.50 on 13-Aug-2024.

Last one week high and low of the scrip stood at Rs. 1461.95 and Rs. 1375.30 respectively. The current market cap of the company is Rs. 26876.55 crore.

The promoters holding in the company stood at 48.01%, while Institutions and Non-Institutions held 13.09% and 38.90% respectively.

Emcure Pharmaceuticals has received approval for the incorporation of a wholly-owned subsidiary (WOS) by the name ‘Emcutix Biopharmaceuticals’ in Pune, Maharashtra, India. WoS is being incorporated to manufacture, promote, sale and distribute pharmaceuticals and other related product(s).  A Committee of the Board of Directors of the Company in their meeting held on September 13, 2024, has inter-alia approved the same. 

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

Emcure Pharma Share Price

1033.00 5.20 (0.51%)
28-Apr-2025 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1812.00
Dr. Reddys Lab 1196.00
Cipla 1547.20
Lupin 2086.90
Zydus Lifesciences 875.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...